1. Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2− advanced or metastatic breast cancer. (2nd December 2018) Authors: Mistry, Rohit; Suri, Gaurav; Young, Kate; Hettle, Robert; May, Jessica R.; Brixner, Diana; Oderda, Gary; Biskupiak, Joseph; Tang, Derek; Bhattacharyya, Devarshi; Bhattacharyya, Subrata; Mishra, Dinesh; Dalal, Anand A. Journal: Current medical research and opinion Issue: Volume 34:Number 12(2018) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗